Suppr超能文献

[冠脉舒对冠心病患者血浆组织型纤溶酶原激活剂及纤溶酶原激活剂抑制剂的影响]

[Effects of guan-mai-shu on tissue-type plasminogen activator and plasminogen activator inhibitor in the plasma of patients with coronary heart disease].

作者信息

Xiong X Z, Mo S S

机构信息

Second Teaching Hospital, Hunan Medical University, Changsha.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1993 Dec;13(12):727-9, 708-9.

PMID:8136646
Abstract

Effects of Guan-Mai-Shu (GMS), a traditional Chinese medicine preparation, on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) in the plasma of patients with coronary heart disease were studied. It was found that those patients had a significant decrease in t-PA activity (P < 0.05) and a significant increase in PAI activity (P < 0.01) compared to healthy subjects. After treatment of GMS, t-PA activity significantly increased (P < 0.001), while PAI activity decreased (P < 0.001). These results indicated that GMS could raise t-PA activity and reduce PAI activity in the plasma of patients with coronary heart disease.

摘要

研究了中药制剂冠脉舒(GMS)对冠心病患者血浆组织型纤溶酶原激活剂(t-PA)和纤溶酶原激活剂抑制剂(PAI)的影响。结果发现,与健康受试者相比,这些患者的t-PA活性显著降低(P<0.05),PAI活性显著升高(P<0.01)。给予GMS治疗后,t-PA活性显著升高(P<0.001),而PAI活性降低(P<0.001)。这些结果表明,GMS可提高冠心病患者血浆中的t-PA活性并降低PAI活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验